Manganese is one of those minerals your body needs in just the right amount. Too little, and the enzymes that defend your cells and fuel your metabolism can't do their jobs. Too much, and it accumulates in the brain, where it can silently damage the same circuits that go wrong in Parkinson's disease. The trouble is that most people never check their level, and standard blood panels don't include it.
A blood manganese test gives you a snapshot of how much of this mineral is circulating in your body right now. Because your body walks a tightrope between needing manganese and being poisoned by it, knowing your number helps you catch imbalances before symptoms appear.
Manganese (Mn) is a trace element you get entirely from food. Once absorbed through the gut, it travels through the bloodstream inside red blood cells and gets distributed to organs with high energy demands: bones, liver, pancreas, kidneys, and especially the brain. Your body keeps manganese in balance through two main levers: how much it absorbs from the intestine and how much the liver clears into bile for excretion.
Inside your cells, manganese activates several enzymes that matter for day-to-day health. One of the most important is manganese superoxide dismutase (MnSOD), which sits inside the energy-producing compartments of your cells (mitochondria) and neutralizes harmful molecules generated during normal metabolism. Manganese is also required for enzymes involved in bone formation, blood sugar regulation, and the brain's ability to recycle its chemical messengers.
The most serious consequence of elevated manganese is damage to the brain. Manganese preferentially accumulates in a cluster of deep brain structures called the basal ganglia, the same area affected in Parkinson's disease. At high concentrations, it disrupts dopamine signaling, triggers inflammation inside the brain, impairs the energy-producing machinery of cells, and causes misfolding of proteins that are supposed to support normal nerve function.
The resulting condition, sometimes called manganism, produces movement problems strikingly similar to Parkinson's: slowness, stiffness, tremor, difficulty walking, and cognitive decline. In children, elevated manganese from contaminated drinking water has been linked to lower IQ scores, attention problems, anxiety, depression, and impaired motor skills. The damage can be progressive and may not fully reverse even after the exposure stops, particularly when the dopamine-producing circuits have already degenerated.
The relationship between manganese and heart disease follows a dose-response pattern that looks like a U: both very low and very high levels are associated with worse outcomes, with a protective zone in the middle. In a large Japanese study of nearly 59,000 adults followed for over 16 years, those with the highest dietary manganese intake had roughly 14% lower risk of dying from cardiovascular disease, 24% lower risk of stroke, and 24% lower risk of ischemic heart disease compared to those with the lowest intake. These associations were strongest in postmenopausal women.
For type 2 diabetes, a meta-analysis pooling over 270,000 participants found a 4% reduction in diabetes risk for each additional milligram of daily dietary manganese. When researchers looked at blood manganese levels in NHANES data, the relationship with death from any cause also followed a U-shaped curve, with the lowest risk in a narrow optimal window around 8.67 to 9.23 micrograms per liter (a unit for very small concentrations in blood).
Manganese and the liver have a two-way relationship. The liver is the organ primarily responsible for clearing manganese from the body through bile. When liver disease impairs this clearance, manganese accumulates in the blood and brain. In patients with cirrhosis (advanced scarring of the liver), higher serum manganese levels have been correlated with more severe and more frequently recurring episodes of hepatic encephalopathy, a condition where toxins that the liver normally clears begin to affect brain function.
Conversely, elevated blood manganese may also contribute to liver damage. In a cross-sectional analysis of over 3,500 U.S. adults, those in the highest third of blood manganese had a positive association with non-alcoholic fatty liver disease (NAFLD). Among women specifically, the highest manganese group had roughly 2.3 times the odds of significant liver scarring (fibrosis) compared to the lowest group. Whether manganese excess contributes to liver disease or simply accumulates because of it (or both) remains an open question.
Evidence linking manganese to cancer risk is limited. The strongest finding comes from the Japanese Collaborative Cohort Study, where men with the highest dietary manganese intake had roughly 44% lower risk of liver cancer compared to those with the lowest intake over nearly 18 years of follow-up. This protective association was even stronger (68% lower risk) among men without pre-existing liver disease. No significant association was found in women. A separate genetic analysis (Mendelian randomization study) suggested that higher genetically predicted serum manganese may protect against acute lymphoblastic leukemia, but this finding has not been replicated.
Manganese does not yet have universally standardized clinical reference ranges the way cholesterol or blood sugar does. The values below are drawn from large population studies, and your lab may use slightly different cutpoints depending on its assay. Women tend to run 15 to 20% higher than men, and levels naturally decrease with age.
| Category | Blood Manganese | What It Suggests |
|---|---|---|
| Typical range | 4 to 15 mcg/L | Normal manganese status for most adults |
| Population average (women) | ~10.6 mcg/L | Mean from NHANES 2011-2012 (7,720 U.S. adults) |
| Population average (men) | ~9.2 mcg/L | Mean from NHANES 2011-2012 (7,720 U.S. adults) |
| Suggested optimal window | 8.67 to 9.23 mcg/L | Lowest all-cause mortality risk in NHANES analysis |
| Upper reference limit | ~18 to 20 mcg/L | 95th percentile in Brazilian population study |
| Elevated, clinical concern | >36 mcg/L | Generally considered to warrant medical evaluation |
These tiers are drawn from published research, not from clinical guideline bodies. Your lab may use different assays and cutpoints. The most meaningful approach is to compare your results within the same lab over time rather than treating any single threshold as absolute.
Blood manganese is an imperfect mirror of what is happening in your tissues. The liver can clear manganese from the blood relatively quickly, which means your blood level can look normal even while manganese is accumulating in the brain. This is the single biggest limitation of this test, and it is why a normal result in someone with neurological symptoms or known exposure should not be taken as reassurance.
A single manganese reading tells you where you stand today, but the real value comes from tracking how your level changes over time. Blood manganese has substantial natural variability: the combined analytical and biological uncertainty can approach 20 to 30%, meaning a single reading could be noticeably higher or lower than your true average. Two readings a few months apart will give you a much more reliable picture of your actual manganese status.
If your first reading falls within the typical 4 to 15 mcg/L range and you have no risk factors for excess exposure, annual monitoring is reasonable. If your level is outside the typical range, or if you have risk factors such as liver disease, occupational exposure to welding fumes or manganese dust, or iron deficiency, retest in three to six months and investigate the cause. For anyone on IV nutrition containing manganese for more than 30 days, regular monitoring is recommended. Always retest at the same lab to make your trend meaningful, since different assays can produce different numbers for the same sample.
Because the brain clears manganese more slowly than the blood does, a rising trend over time may be more clinically important than any single high reading. And if you are making changes to address an elevated level, such as correcting iron deficiency or reducing an environmental exposure, serial testing is the only way to confirm those changes are actually working.
Evidence-backed interventions that affect your Manganese level
Manganese is best interpreted alongside these tests.